William T. Hu

Neurology Emory University, Atlanta, GA 
Frontotemporal dementia, Alzheimer's disease, biomarkers
"William Hu"
Mean distance: 15.07 (cluster 24)
Cross-listing: Alzheimer's Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gangishetti U, Christina Howell J, Perrin RJ, et al. (2018) Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease. Alzheimer's Research & Therapy. 10: 98
Kollhoff AL, Howell JC, Hu WT. (2018) Automation vs. Experience: Measuring Alzheimer's Beta-Amyloid 1-42 Peptide in the CSF. Frontiers in Aging Neuroscience. 10: 253
Kamara DM, Gangishetti U, Gearing M, et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. Journal of Alzheimer's Disease : Jad
Howell JC, Watts KD, Parker MW, et al. (2017) Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers. Alzheimer's Research & Therapy. 9: 88
Gendron TF, Daughrity LM, Heckman MG, et al. (2017) Phosphorylated neurofilament heavy chain: A biomarker of survival for C9ORF72-associated amyotrophic lateral sclerosis. Annals of Neurology
Gendron TF, Chew J, Stankowski JN, et al. (2017) Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis. Science Translational Medicine. 9
Tsvetkova DZ, Bergquist SH, Parker MW, et al. (2017) Fear and Uncertainty Do Not Influence Reported Willingness to Undergo Lumbar Punctures in a U.S. Multi-Cultural Cohort. Frontiers in Aging Neuroscience. 9: 22
Howell JC, Parker MW, Watts KD, et al. (2016) Research Lumbar Punctures among African Americans and Caucasians: Perception Predicts Experience. Frontiers in Aging Neuroscience. 8: 296
Holler CJ, Taylor G, McEachin ZT, et al. (2016) Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia. Molecular Neurodegeneration. 11: 46
Hu WT, Watts KD, Tailor P, et al. (2016) CSF complement 3 and factor H are staging biomarkers in Alzheimer's disease. Acta Neuropathologica Communications. 4: 14
See more...